Inhibikase Therapeutics Inc
(NAS:IKT)
$
1.87
-0.020 (-1.06%)
Market Cap: 246.91 Mil
Enterprise Value: 159.28 Mil
PE Ratio: 0
PB Ratio: 1.47
GF Score: 36/100 Inhibikase Therapeutics Inc (IKT) Transcripts
- 1